Ksilink and Anagenesis Biotechnologies

Ksilink and Anagenesis Biotechnologies

On February 2nd 2016, Ksilink and Anagenesis Biotechnologies announce a collaborative research agreement to apply stem-cell derived disease models of Duchenne Muscular Dystrophy to small molecule therapies discovery and development.   Download the press release in...